IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM

Kylee H. Maclachlan, Carlyn R. Tan, Tala Shekarkhand, Colin Rueda, Andriy Derkach, Hamza Hashmi, Hani Hassoun, Urvi A. Shah, Malin Hultcrantz, Alexander M. Lesokhin, Sham Mailankody, Francesco Maura, Maximillian Merz, Ross Firestone, Eric M. Jurgens, Kevin C. Miller, Sridevi Rajeeve, Sergio Giralt, Gunjan L. Shah, Michael Scordo, Heather J. Landau, Yanming Zhang, Robert Cimera, Maria E. Arcila, Neha Korde, Saad Z. Usmani

Open source

DOI
10.1182/bloodadvances.2025018537
Published
2026-04-15
Container
Blood Advances
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025018537,
  title = {IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM},
  author = {Kylee H. Maclachlan and Carlyn R. Tan and Tala Shekarkhand and Colin Rueda and Andriy Derkach and Hamza Hashmi and Hani Hassoun and Urvi A. Shah and Malin Hultcrantz and Alexander M. Lesokhin and Sham Mailankody and Francesco Maura and Maximillian Merz and Ross Firestone and Eric M. Jurgens and Kevin C. Miller and Sridevi Rajeeve and Sergio Giralt and Gunjan L. Shah and Michael Scordo and Heather J. Landau and Yanming Zhang and Robert Cimera and Maria E. Arcila and Neha Korde and Saad Z. Usmani},
  year = {2026},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2025018537},
  url = {https://doi.org/10.1182/bloodadvances.2025018537}
}

RIS

TY  - JOUR
TI  - IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM
AU  - Kylee H. Maclachlan
AU  - Carlyn R. Tan
AU  - Tala Shekarkhand
AU  - Colin Rueda
AU  - Andriy Derkach
AU  - Hamza Hashmi
AU  - Hani Hassoun
AU  - Urvi A. Shah
AU  - Malin Hultcrantz
AU  - Alexander M. Lesokhin
AU  - Sham Mailankody
AU  - Francesco Maura
AU  - Maximillian Merz
AU  - Ross Firestone
AU  - Eric M. Jurgens
AU  - Kevin C. Miller
AU  - Sridevi Rajeeve
AU  - Sergio Giralt
AU  - Gunjan L. Shah
AU  - Michael Scordo
AU  - Heather J. Landau
AU  - Yanming Zhang
AU  - Robert Cimera
AU  - Maria E. Arcila
AU  - Neha Korde
AU  - Saad Z. Usmani
PY  - 2026
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2025018537
UR  - https://doi.org/10.1182/bloodadvances.2025018537
ER  - 

APA

Maclachlan, K. H., Tan, C. R., Shekarkhand, T., Rueda, C., Derkach, A., Hashmi, H., Hassoun, H., Shah, U. A., Hultcrantz, M., Lesokhin, A. M., Mailankody, S., Maura, F., Merz, M., Firestone, R., Jurgens, E. M., Miller, K. C., Rajeeve, S., Giralt, S., Shah, G. L., Scordo, M., Landau, H. J., Zhang, Y., Cimera, R., Arcila, M. E., Korde, N., & Usmani, S. Z. (2026). IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM. Blood Advances. https://doi.org/10.1182/bloodadvances.2025018537

Source records